Portfolio Holdings Detail for ISIN IE00BYXG2H39
| Stock Name / Fund | iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares IV Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300ZP07LMR36K1T02 |
| ETF Ticker | BTEC(USD) LSE |
| ETF Ticker | BTEK(GBP) LSE |
| ETF Ticker | 2B70(EUR) F |
| ETF Ticker | 2B70.DE(EUR) CXE |
| ETF Ticker | BTEC.LS(USD) CXE |
| ETF Ticker | BTEK.LS(GBP) CXE |
| ETF Ticker | BTEC.L(GBP) LSE |
| ETF Ticker | BTEK.L(GBP) LSE |
Holdings detail for LRMR
| Stock Name | Larimar Therapeutics Inc |
| Ticker | LRMR(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US5171251003 |
| LEI | 529900NCBZHTTJV6HX73 |
Show aggregate LRMR holdings
News associated with LRMR
- Critical Contrast: Larimar Therapeutics (NASDAQ:LRMR) & Redhill Biopharma (NASDAQ:RDHL)
- Larimar Therapeutics (NASDAQ:LRMR – Get Free Report) and Redhill Biopharma (NASDAQ:RDHL – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, valuation and profitability. Risk and Volatility Larimar Therapeutics has a […] - 2025-09-17 04:26:48
- Brokerages Set Larimar Therapeutics, Inc. (NASDAQ:LRMR) PT at $18.43
- Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) has received a consensus recommendation of “Buy” from the nine analysts that are presently covering the firm, MarketBeat reports. Nine equities research analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have covered the stock in the last year […] - 2025-09-17 02:26:48
- JMP Securities Cuts Larimar Therapeutics (NASDAQ:LRMR) Price Target to $18.00
- Larimar Therapeutics (NASDAQ:LRMR – Free Report) had its price objective reduced by JMP Securities from $22.00 to $18.00 in a research note released on Friday morning,Benzinga reports. They currently have a market outperform rating on the stock. LRMR has been the topic of several other research reports. Guggenheim restated a “buy” rating and issued a […] - 2025-08-18 04:46:50
- Larimar Beats Q2 Loss Estimates
- Key PointsGAAP EPS loss of $0.41 in Q2 2025 beat analyst expectations for a larger loss of $0.48 per share. - 2025-08-14 08:33:09
- Financial Analysis: Larimar Therapeutics (NASDAQ:LRMR) & BioVie (NASDAQ:BIVI)
- Larimar Therapeutics (NASDAQ:LRMR – Get Free Report) and BioVie (NASDAQ:BIVI – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability. Risk and Volatility Larimar Therapeutics has a beta […] - 2025-08-01 02:18:59
- Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives $18.50 Average PT from Analysts
- Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) has been assigned an average recommendation of “Buy” from the nine analysts that are currently covering the stock, Marketbeat reports. Eight equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1-year target […] - 2025-07-29 03:06:54
- Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Average Recommendation of “Buy” from Analysts
- Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) have received a consensus rating of “Buy” from the nine analysts that are currently covering the company, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average […] - 2025-07-01 02:30:50
- Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives $19.67 Consensus PT from Analysts
- Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) have earned an average recommendation of “Buy” from the nine ratings firms that are covering the company, MarketBeat Ratings reports. Eight investment analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year […] - 2025-06-09 03:07:13
- Millennium Management LLC Sells 508,912 Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR)
- Millennium Management LLC cut its position in shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) by 66.6% in the fourth quarter, Holdings Channel reports. The institutional investor owned 254,947 shares of the company’s stock after selling 508,912 shares during the period. Millennium Management LLC’s holdings in Larimar Therapeutics were worth $987,000 as of its […] - 2025-06-06 04:38:57
- 14,078 Shares in Larimar Therapeutics, Inc. (NASDAQ:LRMR) Acquired by Graham Capital Management L.P.
- Graham Capital Management L.P. bought a new position in Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 14,078 shares of the company’s stock, valued at approximately $54,000. A number of other hedge funds and other institutional investors […] - 2025-05-20 05:09:24
- Balyasny Asset Management L.P. Makes New $308,000 Investment in Larimar Therapeutics, Inc. (NASDAQ:LRMR)
- Balyasny Asset Management L.P. bought a new position in Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor bought 79,496 shares of the company’s stock, valued at approximately $308,000. Other large investors have also added to or reduced their stakes in the company. SG Americas Securities LLC […] - 2025-05-18 06:16:55
- Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives $19.63 Consensus Price Target from Analysts
- Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) have received a consensus rating of “Buy” from the ten research firms that are presently covering the firm, MarketBeat Ratings reports. Nine investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […] - 2025-05-15 03:10:54
- Algert Global LLC Buys Shares of 12,190 Larimar Therapeutics, Inc. (NASDAQ:LRMR)
- Algert Global LLC bought a new stake in shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund bought 12,190 shares of the company’s stock, valued at approximately $47,000. Other hedge funds and other institutional investors have also recently modified their holdings of the company. Alyeska Investment Group […] - 2025-05-14 05:59:08
- Trexquant Investment LP Lowers Stock Holdings in Larimar Therapeutics, Inc. (NASDAQ:LRMR)
- Trexquant Investment LP lowered its position in shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) by 18.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 123,066 shares of the company’s stock after selling 28,041 shares during the […] - 2025-04-13 05:33:17
- HC Wainwright Forecasts Strong Price Appreciation for Larimar Therapeutics (NASDAQ:LRMR) Stock
- Larimar Therapeutics (NASDAQ:LRMR – Get Free Report) had its target price increased by HC Wainwright from $15.00 to $16.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright also issued estimates for Larimar Therapeutics’ Q1 2025 earnings at ($0.43) EPS, Q2 2025 earnings […] - 2025-03-27 04:32:48
- Robert W. Baird Lowers Larimar Therapeutics (NASDAQ:LRMR) Price Target to $10.00
- Larimar Therapeutics (NASDAQ:LRMR – Free Report) had its price target reduced by Robert W. Baird from $13.00 to $10.00 in a report issued on Tuesday,Benzinga reports. They currently have an outperform rating on the stock. Several other analysts have also issued reports on LRMR. Truist Financial initiated coverage on shares of Larimar Therapeutics in a […] - 2025-03-26 04:46:46
- China Universal Asset Management Co. Ltd. Makes New Investment in Larimar Therapeutics, Inc. (NASDAQ:LRMR)
- China Universal Asset Management Co. Ltd. purchased a new position in Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 13,529 shares of the company’s stock, valued at approximately $52,000. Other institutional […] - 2025-02-04 06:53:04
iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) LRMR holdings
| Date | Number of LRMR Shares Held | Base Market Value of LRMR Shares | Local Market Value of LRMR Shares | Change in LRMR Shares Held | Change in LRMR Base Value | Current Price per LRMR Share Held | Previous Price per LRMR Share Held |
|---|
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of LRMR by Blackrock for IE00BYXG2H39
Show aggregate share trades of LRMR| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-10-06 | BUY | 438 | 4.810 | 4.997 | 4.978 | USD 2,180 | 3.06 |
| 2025-10-03 | BUY | 1,022 | 4.870 | 4.880 | 4.879 | USD 4,986 | 3.05 |
| 2025-10-02 | BUY | 146 | 4.280 | 4.480 | 4.460 | USD 651 | 3.04 |
| 2025-09-30 | BUY | 294 | 3.230 | 3.500 | 3.473 | USD 1,021 | 3.03 |
| 2025-09-26 | BUY | 290 | 5.095 | 5.370 | 5.342 | USD 1,549 | 3.02 |
| 2025-09-25 | BUY | 290 | 4.860 | 5.170 | 5.139 | USD 1,490 | 3.01 |
| 2025-09-24 | BUY | 13,888 | 5.100 | 5.210 | 5.199 | USD 72,204 | 3.00 |
| 2025-09-18 | BUY | 103 | 4.280 | 4.290 | 4.289 | USD 442 | 2.99 |
| 2025-09-17 | BUY | 315 | 4.080 | 4.279 | 4.259 | USD 1,342 | 2.98 |
| 2025-09-11 | SELL | -105 | 4.170 | 4.261 | 4.252 | USD -446 | 2.96  Loss of -136 on sale |
| 2025-09-10 | BUY | 210 | 4.000 | 4.220 | 4.198 | USD 882 | 2.95 |
| 2025-09-05 | SELL | -105 | 3.940 | 4.080 | 4.066 | USD -427 | 2.94 Loss of -119 on sale |
| 2025-08-29 | SELL | -315 | 3.620 | 3.980 | 3.944 | USD -1,242 | 2.92 Loss of -324 on sale |
| 2025-08-27 | BUY | 210 | 3.900 | 3.965 | 3.958 | USD 831 | 2.90 |
| 2025-08-26 | SELL | -105 | 3.870 | 3.880 | 3.879 | USD -407 | 2.90 Loss of -103 on sale |
| 2025-08-25 | BUY | 105 | 3.720 | 3.950 | 3.927 | USD 412 | 2.89 |
| 2025-08-20 | SELL | -420 | 3.770 | 3.860 | 3.851 | USD -1,617 | 2.88 Loss of -407 on sale |
| 2025-08-18 | BUY | 206 | 3.900 | 4.120 | 4.098 | USD 844 | 2.87 |
| 2025-08-08 | SELL | -208 | 3.580 | 3.770 | 3.751 | USD -780 | 2.84 Loss of -189 on sale |
| 2025-08-05 | BUY | 103 | 3.740 | 4.225 | 4.176 | USD 430 | 2.82 |
| 2025-08-01 | SELL | -309 | 3.440 | 3.550 | 3.539 | USD -1,094 | 2.82 Loss of -224 on sale |
| 2025-07-30 | BUY | 412 | 3.570 | 3.885 | 3.853 | USD 1,588 | 2.81 |
| 2025-07-17 | SELL | -208 | 3.320 | 3.395 | 3.387 | USD -705 | 2.76 Loss of -131 on sale |
| 2025-07-11 | SELL | -840 | 3.380 | 3.480 | 3.470 | USD -2,915 | 2.74 Loss of -613 on sale |
| 2025-07-07 | BUY | 315 | 3.200 | 3.220 | 3.218 | USD 1,014 | 2.72 |
| 2025-07-02 | BUY | 5,665 | 3.110 | 3.185 | 3.177 | USD 18,001 | 2.71 |
| 2025-06-25 | BUY | 206 | 3.250 | 3.330 | 3.322 | USD 684 | 2.70 |
| 2025-06-11 | BUY | 206 | 3.100 | 3.230 | 3.217 | USD 663 | 2.69 |
| 2025-06-10 | BUY | 206 | 2.910 | 3.055 | 3.041 | USD 626 | 2.69 |
| 2025-06-04 | SELL | -103 | 2.450 | 2.560 | 2.549 | USD -263 | 2.69  Profit of 15 on sale |
| 2025-04-23 | BUY | 103 | 2.260 | 2.510 | 2.485 | USD 256 | 2.89 |
| 2025-04-10 | SELL | -824 | 1.780 | 1.880 | 1.870 | USD -1,541 | 3.02 Profit of 952 on sale |
| 2025-04-08 | SELL | -103 | 1.710 | 1.990 | 1.962 | USD -202 | 3.06 Profit of 113 on sale |
| 2025-04-07 | SELL | -103 | 1.870 | 1.980 | 1.969 | USD -203 | 3.08 Profit of 115 on sale |
| 2025-04-04 | SELL | -525 | 1.960 | 1.970 | 1.969 | USD -1,034 | 3.10 Profit of 594 on sale |
| 2025-04-01 | BUY | 412 | 2.000 | 2.120 | 2.108 | USD 868 | 3.13 |
| 2025-03-31 | SELL | -315 | 2.150 | 2.260 | 2.249 | USD -708 | 3.15 Profit of 284 on sale |
| 2025-03-14 | SELL | -1,680 | 2.590 | 2.700 | 2.689 | USD -4,518 | 3.32 Profit of 1,053 on sale |
| 2025-03-07 | SELL | -210 | 3.030 | 3.190 | 3.174 | USD -667 | 3.38 Profit of 43 on sale |
| 2025-03-04 | SELL | -105 | 2.790 | 2.840 | 2.835 | USD -298 | 3.41 Profit of 60 on sale |
| 2025-02-25 | BUY | 210 | 2.950 | 3.120 | 3.103 | USD 652 | 3.48 |
| 2025-02-19 | SELL | -105 | 3.310 | 3.510 | 3.490 | USD -366 | 3.52 Profit of 3 on sale |
| 2025-02-13 | BUY | 315 | 3.270 | 3.340 | 3.333 | USD 1,050 | 3.55 |
| 2025-02-12 | BUY | 105 | 3.230 | 3.290 | 3.284 | USD 345 | 3.56 |
| 2025-02-11 | BUY | 420 | 3.150 | 3.310 | 3.294 | USD 1,383 | 3.57 |
| 2025-01-17 | BUY | 420 | 3.340 | 3.389 | 3.384 | USD 1,421 | 3.58 |
| 2025-01-16 | BUY | 420 | 3.250 | 3.474 | 3.452 | USD 1,450 | 3.63 |
| 2025-01-10 | SELL | -210 | 3.660 | 3.750 | 3.741 | USD -786 | 3.86 Profit of 26 on sale |
| 2025-01-08 | SELL | -420 | 3.790 | 3.980 | 3.961 | USD -1,664 | 4.01 Profit of 21 on sale |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of LRMR
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 379,195 | 6,022 | 764,486 | 49.6% |
| 2025-09-18 | 152,831 | 0 | 403,869 | 37.8% |
| 2025-09-17 | 255,757 | 0 | 709,180 | 36.1% |
| 2025-09-16 | 186,801 | 405 | 633,884 | 29.5% |
| 2025-09-15 | 315,022 | 200 | 582,526 | 54.1% |
| 2025-09-12 | 396,681 | 0 | 749,317 | 52.9% |
| 2025-09-11 | 369,503 | 1,400 | 581,616 | 63.5% |
| 2025-09-10 | 437,254 | 4,000 | 1,000,780 | 43.7% |
| 2025-09-09 | 211,298 | 10,493 | 483,655 | 43.7% |
| 2025-09-08 | 239,697 | 0 | 499,598 | 48.0% |
| 2025-09-05 | 321,960 | 15,873 | 744,384 | 43.3% |
| 2025-09-04 | 298,099 | 253 | 483,696 | 61.6% |
| 2025-09-03 | 324,272 | 0 | 689,447 | 47.0% |
| 2025-09-02 | 312,356 | 500 | 785,142 | 39.8% |
| 2025-08-29 | 346,992 | 3,000 | 748,017 | 46.4% |
| 2025-08-28 | 250,242 | 0 | 731,076 | 34.2% |
| 2025-08-27 | 231,280 | 0 | 536,709 | 43.1% |
| 2025-08-26 | 175,786 | 0 | 447,779 | 39.3% |
| 2025-08-25 | 202,315 | 0 | 572,330 | 35.3% |
| 2025-08-22 | 217,163 | 12,872 | 668,556 | 32.5% |
| 2025-08-21 | 180,411 | 600 | 406,606 | 44.4% |
| 2025-08-20 | 344,242 | 657 | 896,050 | 38.4% |
| 2025-08-19 | 313,742 | 2,079 | 751,167 | 41.8% |
| 2025-08-18 | 176,811 | 936 | 455,964 | 38.8% |
| 2025-08-15 | 294,967 | 0 | 728,439 | 40.5% |
| 2025-08-14 | 323,681 | 1,000 | 1,103,680 | 29.3% |
| 2025-08-13 | 173,029 | 1,973 | 618,806 | 28.0% |
| 2025-08-12 | 154,598 | 0 | 480,053 | 32.2% |
| 2025-08-11 | 109,641 | 0 | 337,727 | 32.5% |
| 2025-08-08 | 159,743 | 0 | 541,050 | 29.5% |
| 2025-08-07 | 128,915 | 102 | 360,723 | 35.7% |
| 2025-08-06 | 260,872 | 3,103 | 901,893 | 28.9% |
| 2025-08-05 | 1,104,512 | 32,881 | 3,910,976 | 28.2% |
| 2025-08-04 | 242,855 | 0 | 581,622 | 41.8% |
| 2025-08-01 | 222,566 | 1,145 | 546,592 | 40.7% |
| 2025-07-31 | 231,419 | 778 | 801,631 | 28.9% |
| 2025-07-30 | 243,276 | 1,048 | 1,493,833 | 16.3% |
| 2025-07-29 | 156,583 | 13,030 | 454,615 | 34.4% |
| 2025-07-28 | 63,846 | 165 | 209,358 | 30.5% |
| 2025-07-25 | 116,630 | 186 | 307,504 | 37.9% |
| 2025-07-24 | 172,089 | 0 | 533,269 | 32.3% |
| 2025-07-23 | 175,636 | 8,600 | 1,064,270 | 16.5% |
| 2025-07-22 | 130,550 | 733 | 581,667 | 22.4% |
| 2025-07-21 | 70,157 | 2,240 | 239,277 | 29.3% |
| 2025-07-18 | 93,223 | 6 | 227,202 | 41.0% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Note: All information is provided as is without warranty and should be used for indicative purposes only.
You should independently check data before making any investment decision.
This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.
Copyright Market Footprint Ltd. Privacy Policy